DESMOPRESSIN LYOPHILISATE FOR THE TREATMENT OF CENTRAL DIABETES INSIPIDUS: FIRST EXPERIENCE IN VERY YOUNG INFANTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

WAELE KATHLEEN DE; COOLS MARTINE; DE GUCHTENAERE ANN; DE WALLE JOHAN VAN; RAES ANN; AKEN SARA VAN; COEN KRIS DE; VANHAESEBROUCK PIET; SCHEPPER JEAN DE

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Endocrinology and Metabolism Year:2014 | Volume:12 | Issue:4 Page(s): 1-4

Download Full-Text

View:

330

Download:

122

Cites:

Information Journal Paper

Title

DESMOPRESSIN LYOPHILISATE FOR THE TREATMENT OF CENTRAL DIABETES INSIPIDUS: FIRST EXPERIENCE IN VERY YOUNG INFANTS

Author(s)

Keywords

DESMOPRESSIN

DIABETES INSIPIDUS

INFANT

HYPERNATREMIA

Abstract

Introduction: In neonates and small INFANTs, early diagnosis of central DIABETES INSIPIDUS (CDI) and treatment with DESMOPRESSIN in low doses (avoiding severe hypo- or HYPERNATREMIA) are important to prevent associated high morbidity and mortality in this particular age group.Case Presentation: We described pharmacokinetic and pharmacodynamic results of the use of recently launched oral DESMOPRESSIN lyophilisate (Minirin Melt®) in two INFANTs with CDI, diagnosed at the age of 12 and 62 days, respectively. We observed that a starting dose of 60 μg of Minirin Melt® in the first case resulted in a pharmacokinetic profile largely exceeding the reference frame observed in children with nocturnal enuresis, while a dose of 15 μg in the second case resulted in acceptable concentrations. After initial dose adjustments, administration of sublingual lyophilisate resulted in rather stable serum sodium concentrations.Conclusions: Using Minirin Melt® in INFANTs with CDI appears to be effective, easy to use and well tolerated.

Cites

No record.

References

No record.

Cite

APA: Copy

WAELE, KATHLEEN DE, COOLS, MARTINE, DE GUCHTENAERE, ANN, DE WALLE, JOHAN VAN, RAES, ANN, AKEN, SARA VAN, COEN, KRIS DE, VANHAESEBROUCK, PIET, & SCHEPPER, JEAN DE. (2014). DESMOPRESSIN LYOPHILISATE FOR THE TREATMENT OF CENTRAL DIABETES INSIPIDUS: FIRST EXPERIENCE IN VERY YOUNG INFANTS. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), 12(4), 1-4. SID. https://sid.ir/paper/297513/en

Vancouver: Copy

WAELE KATHLEEN DE, COOLS MARTINE, DE GUCHTENAERE ANN, DE WALLE JOHAN VAN, RAES ANN, AKEN SARA VAN, COEN KRIS DE, VANHAESEBROUCK PIET, SCHEPPER JEAN DE. DESMOPRESSIN LYOPHILISATE FOR THE TREATMENT OF CENTRAL DIABETES INSIPIDUS: FIRST EXPERIENCE IN VERY YOUNG INFANTS. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM)[Internet]. 2014;12(4):1-4. Available from: https://sid.ir/paper/297513/en

IEEE: Copy

KATHLEEN DE WAELE, MARTINE COOLS, ANN DE GUCHTENAERE, JOHAN VAN DE WALLE, ANN RAES, SARA VAN AKEN, KRIS DE COEN, PIET VANHAESEBROUCK, and JEAN DE SCHEPPER, “DESMOPRESSIN LYOPHILISATE FOR THE TREATMENT OF CENTRAL DIABETES INSIPIDUS: FIRST EXPERIENCE IN VERY YOUNG INFANTS,” INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), vol. 12, no. 4, pp. 1–4, 2014, [Online]. Available: https://sid.ir/paper/297513/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops